Klara Dickinson's Net Worth
$32.6 Thousand
Who is Klara Dickinson?
Klara Dickinson does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CymaBay Therapeutics, Inc., COTHERIX INC, HYPERION THERAPEUTICS INC, and Anthera Pharmaceuticals Inc.
SEC CIK
Klara Dickinson's CIK is 0001339895
Past Insider Trading and Trends
2014 was Klara Dickinson's most active year for acquiring shares with 2 total transactions. Klara Dickinson's most active month to acquire stocks was the month of December. 2024 was Klara Dickinson's most active year for disposing of shares, totalling 9 transactions. Klara Dickinson's most active month to dispose stocks was the month of February. 2020 saw Klara Dickinson paying a total of $0.00 for 328,299 shares, this is the most they've acquired in one year. In 2007 Klara Dickinson cashed out on 132,417 shares for a total of $1,116,695.74, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CymaBay Therapeutics, Inc. (CBAY) No price found
Chief Regulatory OfficerKlara Dickinson used to own units in Common Stock but no longer holds any shares there. In the year 2024 Klara Dickinson filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -21.00K |
—
|
—
|
0
|
Mar 22
| |||
Form 4
|
∞
| 21K |
—
|
—
| 21K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
COTHERIX INC No price found
VP, Regulatory AffairsKlara Dickinson used to own units in Common Stock but no longer holds any shares there.disposed a total of 2,417 shares of COTHERIX INC equalling to $32,629.50.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.42K |
$13.50 | -$32,629.50 |
0
|
Jan 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
HYPERION THERAPEUTICS INC No price found
SVP Reg. Affairs & ComplianceKlara Dickinson owns 2,283 units of Common Stock. In the year 2012 Klara Dickinson filed a total of 4 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +706.71% | 2K |
—
|
—
| 2.28K |
Mar 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 15
| |||
Form 4
| +5,560.00% | 278 |
—
|
—
| 283 |
Jul 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Anthera Pharmaceuticals Inc No price found
SVP & Chief Regulatory Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||